Guanazodine
Chemical compound
- C02CC06 (WHO)
- 2-(Azocan-2-ylmethyl)guanidine
- 32059-15-7
- 36054
- 33166
- 7N05KQ38YI
- D07169 Y
- ChEMBL2008565
- DTXSID30953934
- Interactive image
- C1CCCNC(CC1)CNC(=N)N
InChI
- InChI=1S/C9H20N4/c10-9(11)13-7-8-5-3-1-2-4-6-12-8/h8,12H,1-7H2,(H4,10,11,13)
- Key:ZCVAIGPGEINFCX-UHFFFAOYSA-N
Guanazodine is an anti-hypertensive sympatholytic drug. [1][2][3]
References
- ^ Shimizu T, Hamakawa H, Tozuka T, Ono H (October 1976). "[Pharmacological effects of [(octahydro-2-azocinyl)methyl] guanidine(guanazodine): its action mechanism and hypotensive effect]". Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica (in Japanese). 72 (7): 837–50. doi:10.1254/fpj.72.837. PMID 1035187.
- ^ "Drugbank Online - Guanazodine".
- ^ "National Center for Advancing Translational Sciences".
- v
- t
- e
(antagonize α-adrenergic
vasoconstriction)
Central |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Peripheral |
|
Serotonin receptor antagonists | |
---|---|
Endothelin receptor antagonists (for PHTooltip Pulmonary hypertension) |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e